Company / Shareholders' Equity
Evolent Health, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$415.2M
FY2025
5-year range
$415.2M / $1.1B
FY2021-FY2025
Trend
-58.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $415M in FY2025 to $1.1B in FY2018.
Based on SEC 10-K filings.
$415M in FY2025 with a 5-year CAGR of -7.7%.
Declined from $1.1B to $415M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -21.5%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.7%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 58.5% year-over-year.
- Peak shareholders' equity was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $415.2M | -58.5% |
| FY2024 | $1.0B | -6.2% |
| FY2023 | $1.1B | +24.2% |
| FY2022 | $859.4M | +23.9% |
| FY2021 | $693.6M | +11.9% |
| FY2020 | $619.6M | -33.3% |
| FY2019 | $929.0M | -18.8% |
| FY2018 | $1.1B | +13.2% |
| FY2017 | $1.0B | +43.9% |
| FY2016 | $702.5M | +8.2% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026